Schrödinger, Inc.

NASDAQ:SDGR

Medical - Healthcare Information Services

Healthcare
$27.20 +0.01%

+$0.00 today

Market cap
$1.79B
Beta
1.64
P/E (TTM)
-11.1
EPS (TTM)
-$1.40
52W Low $10.95High $23.75

Volume 1.18M

Average 1.35M

SDGR Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Schrödinger, Inc.NASDAQ: SDGR

Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026

Cost of revenue dips below year-ago levels

Q3 FY2026 cost of revenue of $26.24M fell 0.2% year over year, behind the +3.9% change in trailing-twelve-month cost of revenue. Sequentially, it fell 0.8% from the prior quarter. Over 3 fiscal years it compounded at +12.3% a year.

Context

  • Cost of revenue amounted to 44.3% of revenue in FY2025, up 7.9 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -0.2% toward the trailing-twelve-month pace of +3.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$26.24M-0.8% QoQ
Last fiscal yearDec 2025
$113.26M+50.1% YoY
LTMSep 2026
$111.68M+3.9% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.2%——
1 year+50.1%——
3-year CAGR+12.3%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
113.26M USD
Year-over-year change
+50.1%
4-year CAGR
+11.9%

Cost of Revenue vs competitors

How SDGR compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +3.9% is the 3rd highest of 7, against a peer median of -15.9%.
  • Cost of revenue amounts to 41.5% of revenue for SDGR, versus a peer median of 39.7%.
SDGR Competitors
Cost of Revenue for SDGR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VEEVVeeva Systems Inc.LTM Jul 2026$868.21M USD+19.8%+8.7%25.1%
CERTCertara, Inc.LTM Mar 2026$175.81M USD+12.1%+6.7%41.9%
SDGRSchrödinger, Inc.LTM Sep 2026$111.68M USD+3.9%+12.3%41.5%
ABCLAbCellera Biologics Inc.LTM Sep 2026$80.53M USD—-24.3%118.7%
RLAYRelay Therapeutics, Inc.LTM Jun 2026$68.99M USD-65.9%-75.5%666.6%
SLPSimulations Plus, Inc.LTM Feb 2026$30.63M USD-12.8%+44.9%38.0%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$7.28M CAD-18.9%+9.4%39.7%
LTRNLantern Pharma Inc.LTM Mar 2026$3.85K USD-92.5%——
GENBGenerate Biomedicines, Inc.FY2025$0 USD——0.0%
Peer median (excluding SDGR) —-15.9%+7.7%39.7%

Competitors are the stored peer set for SDGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue137.93M180.96M216.67M207.54M255.87M
Cost of Revenue72.31M79.93M75.97M75.46M113.26M
Gross Profit65.62M101.02M140.69M132.08M142.61M
Gross Margin47.6%55.8%64.9%63.6%55.7%
Research & Development90.9M126.37M181.77M201.79M173.14M
Selling, General & Admin86.16M121.47M136.37M139.59M136.37M
Operating Expenses177.06M247.84M318.14M341.38M309.51M
Depreciation & Amortization2.85M4.34M5.55M6.16M6.02M
EBITDA(97.96M)(144.78M)48.47M(179.55M)(96.3M)
EBITDA Margin-71.0%-80.0%22.4%-86.5%-37.6%
Operating Income(111.44M)(146.82M)(177.45M)(209.3M)(166.9M)
Operating Margin-80.8%-81.1%-81.9%-100.8%-65.2%
Interest Income1.06M3.95M000
Interest Expense03K000
Other Income / Expenses10.64M(2.31M)220.37M23.59M64.57M
Income Before Tax(100.81M)(149.12M)42.92M(185.71M)(102.33M)
Pre-Tax Margin-73.1%-82.4%19.8%-89.5%-40.0%
Income Tax Expense411K63K2.2M1.41M939K
Net Income(100.39M)(149.19M)40.72M(187.12M)(103.27M)
Net Margin-72.8%-82.4%18.8%-90.2%-40.4%
EPS (Basic)(1.43)(2.10)0.57(2.57)(1.41)
EPS (Diluted)(1.43)(2.10)0.54(2.57)(1.41)
Weighted Avg Shares70.59M71.17M71.78M72.67M73.44M
Weighted Avg Shares (Diluted)70.59M71.17M74.99M72.67M73.44M

Schrödinger, Inc.

NASDAQ:SDGR

Intrinsic Alpha fair value

Locked

Current Price

$27.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.